Zürich17°Clear
Filtered by Topic
Latest Pharma news and updates from Switzerland. AI-curated articles covering Pharma topics.
← Show All NewsPharma
Basel-based pharmaceutical firm Sandoz has agreed to pay a total of nearly $480 million to settle a long-running US antitrust litigation concerning alleged price-fixing in the generics market. The company does not admit guilt as part of the settlement.
29 days ago · 1 source
Business
Basel-based pharma giant Sandoz is closely monitoring a US proposal to impose heavy tariffs on generic medicines. The move, aimed at reshoring pharmaceutical production to the US, could have significant implications for the Swiss company's global strategy and future investments.
SWI swissinfo.ch
Pharma
Swiss generics giant Sandoz has submitted a draft complaint to the European Commission against what it calls heavily subsidized, low-priced antibiotic imports from China, warning of a 'critical strategic vulnerability' for public health.
SWI swissinfo.ch
Business
Swiss pharmaceutical giant Roche is significantly expanding its footprint in digital pathology with the acquisition of US-based AI firm PathAI. The deal aims to merge Roche's diagnostic expertise with AI-powered systems to accelerate drug development and advance personalized medicine.
SWI swissinfo.ch
Business
Swiss multinationals are making significant investments in the United States, with ABB's CEO identifying the US as the top growth market and Novartis beginning construction on a new $23 billion biomedical research hub in San Diego.
SWI swissinfo.ch · +1 more
Business
Swiss pharmaceutical giant Novartis has begun construction on a new global biomedical research center in San Diego, USA. The facility is a key part of a planned $23 billion US investment and will focus on neuroscience, oncology, and regenerative medicine, expanding the company's research footprint outside of Switzerland.
SWI swissinfo.ch
